Home Stock

Stock Research: GSK

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

GSK

LSE:GSK GB0009252882
10
  • Value
    84
  • Growth
    23
  • Safety
    Safety
    6
  • Combined
    10
  • Sentiment
    30
  • 360° View
    360° View
    10
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

GSK plc is a global biopharma company focused on developing medicines and vaccines. It operates in the pharmaceuticals industry, with a focus on respiratory, immunology, oncology, HIV, and infectious diseases. GSK's operations are global. In the last fiscal year, the company had a market cap of $76,670 million, profits of $28,223 million, and revenue of $39,254 million, with 68629 employees.

more
Strongest Rank Refinancing
Weakest Rank Dividend Yield
Country United Kingdom
Industry Pharmaceuticals
Size XX-Large
Website gsk.com
Index
FTSE All Shares
FTSE 100
FTSE 350
Dividends Europe
Employee Focus EU
Diversity Europe
Human Rights
GSK stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
84 88 89 86
Growth
23 16 55 21
Safety
Safety
6 20 8 1
Sentiment
30 69 70 16
360° View
360° View
10 54 63 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
9 13 19 33
Opinions Change
50 81 71 16
Pro Holdings
n/a 87 80 78
Market Pulse
48 52 65 25
Sentiment
30 69 70 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
84 88 89 86
Growth
23 16 55 21
Safety Safety
6 20 8 1
Combined
10 38 46 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
85 91 89 87
Price vs. Earnings (P/E)
62 50 67 85
Price vs. Book (P/B)
13 20 26 34
Dividend Yield
90 96 96 92
Value
84 88 89 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
35 42 39 37
Profit Growth
38 38 58 23
Capital Growth
17 17 64 6
Stock Returns
73 32 52 78
Growth
23 16 55 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
10 13 6 7
Refinancing
3 11 9 1
Liquidity
49 71 45 41
Safety Safety
6 20 8 1

Similar Stocks

Discover high‑ranked alternatives to GSK and broaden your portfolio horizons.

Krka

LJSE:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Quilter

LSE:QLT
Country: United Kingdom
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews